井上 匡美 いのうえ まさよし 先生

来歴等

略歴

1990年 大阪大学医学部 卒業
1998年 大阪大学大学院医学系外科学 修了
1998年 大阪府立羽曳野病院呼吸器外科
2000年 ドイツ・フンボルト財団奨学研究員としてWuerzburg大学病理部 留学
2002年 国立療養所刀根山病院呼吸器外科
2004年 大阪大学心臓血管呼吸器外科 助手
2008年 大阪大学呼吸器外科学 講師
2012年 大阪大学移植医療部 副部長兼任
2014年 大阪大学呼吸器外科学 准教授
2015年 京都府立医科大学呼吸器外科学 教授

論文

• 1.Programmed death-ligand 1 expression profiling in thymic epithelial cell tumors. Lung Cancer 2020.

  Ishihara S, Inoue M, et al.

• 2.Feasibility of postoperative adjuvant chemotherapy using carboplatin plus S-1 in completely resected non-small cell lung cancer patients. J Chemother. 2019.

  Inoue M, Kusumoto H, et al.

• 3.Long-term prognostic impact of severe postoperative complications after lung cancer surgery. Ann Surg Oncol. 2019.

  Okada S, Inoue M.

• 4.CD-DST for adjuvant chemotherapy after complete resection of non-small-cell lung cancer. Surg Today. 2018.

  Inoue M, Maeda H, et al.

• 5.Risk stratification according to the prognostic nutritional index for predicting postoperative complications after lung cancer surgery. Ann Surg Oncol. 2018.

  Okada S, Inoue M.

• 6.Significance of PD-L1 expression in pulmonary metastases from head and neck squamous cell carcinoma. Surgical Oncol 2018.

  Okada S, Inoue M.

• 7.Results of treatment for thymic neuroendocrine tumours: multicentre clinicopathological study. Interact Cardiovasc Thorac Surg. 2018.

  Ose N, Inoue M, et al.

• 8.Clinical significance of prognostic nutritional index after surgical treatment in lung cancer. Ann Thorac Surg. 2017.

  Okada S, Inoue M, et al.

• 9.Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: The Japanese Lung Cancer Registry Study 2004. Lung Cancer. 2014.

  Inoue M, Okumura M, et al.

• 10.An accurate and rapid detection of lymph node metastasis in non-small cell lung cancer patients based on one-step nucleic acid amplification assay. Lung Cancer. 2012.

  Inoue M, Hiyama K, et al.

• 11.Risk of pleural recurrence after computed tomographic-guided percutaneous needle biopsy in stage I lung cancer patients. Ann Thorac Surg. 2011.

  Inoue M, Honda O, et al.

• 12.Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer. Eur J Cariothoracic Surg 2010.

  Inoue M, Minami M, et al.

• 13.Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of the lung. J Thorac Cardiovasc Surg 2008.

  Inoue M, Takakuwa T, et al.

• 14.Clinicopathologic study of resected, peripheral, small-sized, non–small cell lung cancer tumors of 2 cm or less in diameter: J Thorac Cardiovasc Surg 2006.

  Inoue M, Minami M, et al.

• 15. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg. 2004.

  Inoue M, Ohta M, et al.

• 16.Results of surgical intervention for p-stage IIIA(N2) non-small cell lung cancer: Acceptable prognosis predicted complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg. 2004.

  Inoue M, Sawabata N, et al.

• 17.Correlating genetic aberrations with world health organization-defined histology and stage across the spectrum of thymoma. Cancer Res 2003.

  Inoue M, Mueller-Hermelink HK, et al.

• 18.Chromosome 6 suffers frequent and multiple aberrations in thymoma. Am J Pathol 2002.

  Inoue M, Marx A, et al.

• 19.Surgical results for small cell lung cancer based on the new TNM staging system. Ann Thorac Surg 2000.

  Inoue M, Miyoshi S, et al.

• 20.Results of preoperative mediastinoscopy for small cell lung cancer. Ann Thorac Surg 2000.

  Inoue M, Nakagawa K, et al.

• 21.Surgery for pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 2000.

  Inoue M, Kotake Y, et al.

• 22.Impaired expression of MHC class II molecules in response to interferon-gamma on human thymoma neoplastic epithelial cells. Clin Exp Immunol 1999.

  Inoue M, Okumura M, et al.

• 23.Immaturity of lymphocytes in the metastatic lesions of thymoma. Clin Immunol Immunopathol 1998.

  Inoue M, Okumura M, et al.

• 24.Neoplastic thymic epithelial cells of human thymoma support T cell development from CD4-CD8- cells to CD4+CD8+ cells in vitro. Clin Exp Immunol 1998.

  Inoue M, Fujii Y, et al.

著書

• 1.Chan JKC, Zettl A, Inoue M, et al. Metaplastic thymoma. P.169-170. In Travis WD, Brambilla E, Mueller-Hermelink HK, Harris CC, eds. WHO classification of tumours. Pathology & Genetics. Tumours of the Lung, Pleura, Thymus, and Heart. IARC press, Lyon, 2004.

その他

• 【受賞】2011年 日本呼吸器外科 学会賞